Martin E. Garaycoechea

Florencio Varela, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications.

Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications.

Journal: Hepatology (Baltimore, Md.)

Published: February 14, 2025

Corrigendum to "Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease".

Corrigendum to "Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease".

Journal: EBioMedicine

Published: December 19, 2024

Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease.

Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: EBioMedicine

Published: October 03, 2023

The influence of host genetics on liver microbiome composition in patients with NAFLD.

The influence of host genetics on liver microbiome composition in patients with NAFLD.

Journal: EBioMedicine

Published: September 27, 2021

Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease.

Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease.

Journal: Journal of internal medicine

Published: April 09, 2020

Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease.

Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease.

Journal: Gut

Published: March 29, 2019

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease.

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease.

Journal: Journal of lipid research

Published: September 18, 2018

A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis.

A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis.

Journal: Hepatology communications

Published: April 10, 2018

Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage.

Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage.

Journal: Hepatology communications

Published: February 01, 2018

Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.

Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.

Journal: Scientific reports

Published: August 01, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026